OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

J. R. Currier; M. De Souza; S. Ratto-Kim; R. Paris; V. Nguay; J. Cox; P. Earl; B. Moss; S. Sriplienchan; P. Thongcharoen; J. Kim; M. Robb; N. Michael; M. Marovich

doi:10.1186/1742-4690-6-S3-O27

OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

J. R. Currier^*, M. De Souza, S. Ratto-Kim, R. Paris, V. Nguay, J. Cox, P. Earl, B. Moss, S. Sriplienchan, P. Thongcharoen, J. Kim, M. Robb, N. Michael, M. Marovich

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Article number	1742
Pages (from-to)	O27
Journal	Retrovirology
Volume	6
Issue number	SUPPL. 3
DOIs	https://doi.org/10.1186/1742-4690-6-S3-O27
State	Published - 22 Oct 2009
Externally published	Yes

Access to Document

10.1186/1742-4690-6-S3-O27

Cite this

Currier, J. R., De Souza, M., Ratto-Kim, S., Paris, R., Nguay, V., Cox, J., Earl, P., Moss, B., Sriplienchan, S., Thongcharoen, P., Kim, J., Robb, M., Michael, N., & Marovich, M. (2009). OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial. Retrovirology, 6(SUPPL. 3), O27. Article 1742. https://doi.org/10.1186/1742-4690-6-S3-O27

@article{77462c377aac40bd9b75eac4aaa00b10,

title = "OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial",

author = "Currier, {J. R.} and {De Souza}, M. and S. Ratto-Kim and R. Paris and V. Nguay and J. Cox and P. Earl and B. Moss and S. Sriplienchan and P. Thongcharoen and J. Kim and M. Robb and N. Michael and M. Marovich",

year = "2009",

month = oct,

day = "22",

doi = "10.1186/1742-4690-6-S3-O27",

language = "English",

volume = "6",

pages = "O27",

journal = "Retrovirology",

issn = "1742-4690",

number = "SUPPL. 3",

}

Currier, JR, De Souza, M, Ratto-Kim, S, Paris, R, Nguay, V, Cox, J, Earl, P, Moss, B, Sriplienchan, S, Thongcharoen, P, Kim, J, Robb, M, Michael, N & Marovich, M 2009, 'OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial', Retrovirology, vol. 6, no. SUPPL. 3, 1742, pp. O27. https://doi.org/10.1186/1742-4690-6-S3-O27

TY - JOUR

T1 - OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

AU - Currier, J. R.

AU - De Souza, M.

AU - Ratto-Kim, S.

AU - Paris, R.

AU - Nguay, V.

AU - Cox, J.

AU - Earl, P.

AU - Moss, B.

AU - Sriplienchan, S.

AU - Thongcharoen, P.

AU - Kim, J.

AU - Robb, M.

AU - Michael, N.

AU - Marovich, M.

PY - 2009/10/22

Y1 - 2009/10/22

UR - http://www.scopus.com/inward/record.url?scp=70449678775&partnerID=8YFLogxK

U2 - 10.1186/1742-4690-6-S3-O27

DO - 10.1186/1742-4690-6-S3-O27

M3 - Comment/debate

AN - SCOPUS:70449678775

SN - 1742-4690

VL - 6

SP - O27

JO - Retrovirology

JF - Retrovirology

IS - SUPPL. 3

M1 - 1742

ER -

OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

Access to Document

Fingerprint

Cite this